Article Details
Retrieved on: 2024-06-22 00:51:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche has tapped the biotech start-up Ascidian Therapeutics to discover and develop RNA exon–editing medicines. Ascidian “rewrites” RNA by editing ...
Article found on: cen.acs.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here